A TAT peptide-delivered molecular beacon was developed and utilized to enumerate murine norovirus 1, a human norovirus (NoV) surrogate, in RAW 264.7 cells. This allowed the detection of a single infective virus within 6 h, a 12-fold improvement in time required for viral detection and quantification compared to that required by the conventional plaque assay.Human norovirus (NoV) causes significant negative health and economic impacts around the world (6,7,8). In the United States, norovirus has been implicated as the causative agent of 23 million cases of gastroenteritis and 50,000 hospitalizations annually (6, 10). Currently, no treatment or vaccine is available to prevent this disease. Attempts have been made to cultivate NoV in the laboratory, including a cell culture model employing three-dimensional (3D) human small intestinal epithelium cells (4,13). This method is difficult to perform and not sufficiently robust for routine use (4, 13). Therefore, murine norovirus (MNV) has been increasingly used as a surrogate for human NoV, as MNV possesses similar biological and molecular properties (1,18).In this study, a molecular beacon (MB) targeting the MNV-1 virus was designed. Molecular beacons are increasingly used for real-time monitoring of virus replication in living cells. They have been used successfully in many in vitro hybridization assays due to their sensitivity and specificity and their ability to provide label-based and separation-free detection (5,9,15,16,19,20). Molecular beacons are single-stranded, dually labeled antisense oligonucleotide-nucleotide probes having a stemloop structure, with a fluorophore at one arm and a quencher at the other (5, 15) (Fig. 1). These highly target-specific probes produce fluorescence immediately upon binding, and they can distinguish single-nucleotide mismatches (9,15,20). Conjugation of the MB to the human immunodeficiency virus type 1 (HIV-1)-derived TAT peptide at the N terminus of the peptide using a thiol-maleimide linkage facilitates the traversing of biological membranes with nearly 100% efficiency. The TAT peptide-conjugated MB (TAT-MB) can be used to target complementary mRNA (2,11,14). In this study, a TAT-MB was developed to detect MNV-1 infection of RAW 264.7 cells.Molecular beacon development. A 23-bp region of the 5Ј untranslated region of MNV-1 virus was used as the target. The DNA backbone was modified with sulfur-substituted 2Ј-O-methyl oligoribonucleotides for improved nuclease resistance as described by Tsourkas et al. (14). Stem sequences were added, and mfold software (http://mfold.rna.albany .edu/?qϭmfold/DNA-Folding-Form) and IDT SciTools were used to predict the thermodynamic properties and secondary structures of the MB. The MNV MB sequence is as follows: 5Ј-6-FAM-GCGACATGTCTGATTAGTGGGT TGGTTGTTGTC/thiol-dGC-DABCYL-3Ј (where 6-FAM is 6-carboxyfluorescein) (stem sequence underlined). DA BCYL [4-(4-dimethylaminophenylazo)benzoic acid] possessing a 2Ј-O-methylribonucleotide backbone with phosphorothioate internucleotide linkages was synthesize...